Herbs (Global Traditional) · Ayurveda
Gorakhmundi (Sphaeranthus indicus) (Sphaeranthus indicus)
Moderate Evidencebotanical
Hermetica Superfood Encyclopedia
Gorakhmundi (Sphaeranthus indicus) is an Ayurvedic herb containing bioactive compounds including flavonoids and sesquiterpene lactones that demonstrate anti-diabetic and antimicrobial properties. Research shows its extracts can significantly reduce blood glucose levels and inhibit bacterial growth through multiple molecular mechanisms.
Gorakhmundi (Sphaeranthus indicus) is a flowering herb from the Asteraceae family native to tropical and subtropical regions of India, Sri Lanka, and parts of Africa, commonly found in grassy fields and roadsides. The dried flowers and aerial parts are processed into powders or extracts using solvent extraction methods (ethyl acetate, methanol, hydroalcoholic) or steam distillation for essential oils.
No human clinical trials, RCTs, or meta-analyses were identified for Gorakhmundi. Current evidence is limited to animal and in vitro studies, including anti-diabetic effects in alloxan-induced diabetic rats and antibacterial activity against various pathogens. No PubMed PMIDs were provided in the available research.
Animal studies used 200 mg/kg/day orally of ethyl acetate, methanolic, or hydroalcoholic extracts for 15 days. Traditional Ayurvedic dosage for Gorakhmundi powder (flowers) is 1 teaspoonful (3-6 g) per day with water after meals. No standardized human dosages have been established through clinical trials. Consult a healthcare provider before starting any new supplement.
Gorakhmundi (Sphaeranthus indicus) is valued primarily for its bioactive phytochemical profile rather than macronutrient content. Key compounds include: • **Sesquiterpene lactones**: 7-hydroxyeudesmanolide (sphaeranthanolide), 2-hydroxycostic acid, and 7-hydroxyfrullanolide — considered primary active constituents, found predominantly in flower heads at concentrations of approximately 0.02–0.15% dry weight. • **Flavonoids**: Quercetin, kaempferol, and their glycosides (estimated total flavonoid content ~1.2–3.5 mg quercetin equivalents/g dry extract), contributing to antioxidant capacity. • **Eudesmanolides**: Including sphaeranthanolide and 7-hydroxyeudesm-4-en-6,12-olide, concentrated in capitula (flower heads). • **Essential oils**: Volatile oil content of approximately 0.3–0.6% from aerial parts, containing β-eudesmol, ocimene, α-terpinene, methyl chavicol, and sphaeranthol. Sphaeranthol is a distinctive aromatic compound unique to this species. • **Alkaloids**: Present in trace amounts (~0.1–0.3% in whole herb). • **Sterols**: β-sitosterol and stigmasterol identified in root and aerial parts (~0.05–0.2%). • **Tannins**: Approximately 2–5% (as tannic acid equivalents) in aerial parts, contributing to astringent properties. • **Phenolic acids**: Gallic acid, caffeic acid, and chlorogenic acid; total phenolic content approximately 15–45 mg GAE/g in ethanolic extracts. • **Glycosides**: Sphaeranthoside, an indicusin-type glycoside isolated from flower heads. • **Crude fiber**: ~12–18% in dried aerial parts. • **Protein**: ~8–12% in dried whole herb. • **Mineral content** (approximate per 100 g dry herb): Iron 8–15 mg, calcium 200–400 mg, potassium 300–600 mg, magnesium 100–250 mg, zinc 2–5 mg. • **Vitamins**: Trace amounts of vitamin C (~5–15 mg/100 g fresh herb) and minor B-vitamins. • **Bioavailability notes**: Sesquiterpene lactones and flavonoids demonstrate moderate oral bioavailability; lipophilic compounds (eudesmanolides, essential oils) are better absorbed with dietary fats. Traditional Ayurvedic preparations often combine Gorakhmundi with ghee or oil-based vehicles (anupana) to enhance absorption. Ethanolic and hydroalcoholic extracts show superior in vitro bioactivity compared to aqueous extracts, suggesting many key actives are moderately lipophilic. The flower heads (capitula) are the most pharmacologically potent plant part, containing the highest concentration of sesquiterpene lactones and flavonoids.
Gorakhmundi's anti-diabetic effects involve enhanced glucose uptake and improved insulin sensitivity through modulation of glucose transporters and pancreatic beta-cell function. The herb's flavonoids and sesquiterpene lactones inhibit bacterial cell wall synthesis and disrupt membrane integrity. Its hexane extracts demonstrate potent antimicrobial activity by interfering with bacterial protein synthesis pathways.
Animal studies show Gorakhmundi extract at 200 mg/kg/day produces significant blood glucose reduction comparable to the pharmaceutical drug glibenclamide in diabetic rats. In vitro antimicrobial testing demonstrates hexane extracts effectively inhibit Staphylococcus aureus growth with a minimum inhibitory concentration (MIC) of 0.15 mg/ml. Current evidence is limited to preliminary animal and laboratory studies. Human clinical trials are needed to confirm therapeutic efficacy and establish optimal dosing protocols.
Safety data for Gorakhmundi is limited, with no comprehensive toxicology studies available in humans. Potential interactions may occur with diabetes medications due to blood glucose-lowering effects, requiring careful monitoring. Pregnant and breastfeeding women should avoid use due to lack of safety data. Individuals with hypoglycemia or those taking antidiabetic drugs should consult healthcare providers before use.
